CortheraBio

Core Products

Focus on Developing Undruggable Targets and First-in-Class Innovative Drugs

Cothera Bioscience is focusing on developing therapeutics for previous undruggable oncology targets with high unmet medical needs.  Current pipeline includes three clinical stage programs targeting Myc and KRAS.

CortheraBio
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.